NK510 cell therapy for advanced gastric and colorectal cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests a new natural killer (NK) cell therapy called NK510 for people with advanced gastric or colorectal cancer that has not responded to at least two prior treatments. The study aims to see if NK510 can help shrink tumors or slow the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have gastric cancer (not a type that makes AFP protein) or colorectal cancer that cannot be removed with surgery.
- Your cancer has grown or come back after at least 2 prior treatments.
- You have a tumor that can be measured on a CT or MRI scan.
- You are well enough to be up and about (ECOG score 0-2) and expected to live at least 3 more months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of immune cell therapy (CAR-NK cells) designed to fight advanced colorectal cancer that has spread or cannot be surgically removed. The therapy is customized to target specific protein markers on your cancer cells.
This study tests a natural killer (NK) cell therapy combined with standard maintenance treatment for people with certain advanced cancers (non-small cell lung, colorectal, liver, or stomach cancer) that have not progressed after first-line therapy. It is for people who have completed initial treatment and whose disease is stable or responding.
This trial tests a new natural killer (NK) cell therapy, NK510, for people with advanced non-small cell lung cancer who have already tried immunotherapy and it stopped working. The goal is to see if NK510 is safe and can shrink tumors or slow the cancer's growth.
This trial tests a new immune cell treatment called NK521 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if this therapy can help shrink tumors, including in patients with liver cancer, ovarian cancer, or malignant ascites (fluid buildup in the belly with cancer cells).
This trial tests a new therapy that uses your own natural killer (NK) cells, modified to better fight cancer and injected directly into your abdomen. It's for people with advanced ovarian cancer who cannot have surgery or whose tumor cannot be fully removed.
This trial tests a new type of immune cell therapy (PD-1-M1-NK cells) for people with advanced stomach or colorectal cancer that hasn't responded to at least two prior treatments. The goal is to see if these special cells can attack the cancer more effectively.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.